Dialister

Dialister is a genus of Gram-negative, obligate anaerobic bacteria within the family Veillonellaceae that represents one of the strongest protective associations in gut-brain-axis research. Dialister depletion is a consistent and independent biomarker of depression, anxiety, and neurodevelopmental disorders. The genus is also a major succinate producer and is enriched in healthy periodontal microbiota, suggesting protective roles in both neuropsychiatric and oral health domains.

Taxonomy

  • Phylum: Firmicutes (reclassified)
  • Family: Veillonellaceae
  • Genus: Dialister
  • Key species: D. invisus, D. pneumosintes, D. micraerophilus
  • Characteristic: Gram-negative rods; obligate anaerobes; require formate for growth (formate-dependent) in many species; succinate fermenters

Depression and Neuropsychiatric Associations

Depletion as a Biomarker

Dialister abundance is one of the most consistent protective markers in depression research. Multiple independent cohorts demonstrate:

  • Significantly lower relative abundance (often <0.5% in depressed individuals vs. >2% in healthy controls) [1] [2]
  • Inverse correlation with depressive symptom severity (PHQ-9 scores, Hamilton depression scores)
  • Restoration of Dialister abundance associated with antidepressant response in both pharmacological and lifestyle interventions [3]
  • Depletion predicts treatment-resistant depression

Mechanistic Links to Neuropsychiatry

  1. Succinate Production and Mitochondrial Function
  • Dialister's primary metabolic output is succinate, a key Krebs cycle intermediate and signaling molecule
  • Succinate deficiency in depression correlates with mitochondrial dysfunction in hippocampal neurons
  • Oral succinate supplementation (in rodent models) partially reverses Dialister depletion phenotypes
  1. Short-Chain Fatty Acid Dysbiosis
  • Dialister depletion co-occurs with reduced butyrate and propionate production
  • Butyrate is essential for histone deacetylase (HDAC) inhibition, which promotes BDNF expression in the brain
  • Loss of Dialister contributes to reduced BBB integrity via claudin-5 downregulation
  1. Lipopolysaccharide (LPS) and Neuroinflammation
  • Gram-negative Dialister species produce endotoxin, but their presence appears to maintain homeostatic immune tolerance
  • Dialister depletion allows overgrowth of more aggressive Gram-negative pathogens (e.g., enterobacteriaceae) with more inflammatory LPS patterns
  • The shift in endotoxemia profile (not just total LPS load) drives microglia activation and neuroinflammation
  1. Vagal Signaling and the Gut-Brain Axis
  • Dialister metabolites activate GPR43/GPR41 receptors on enteric neurons
  • Loss of Dialister reduces afferent vagal signaling, impairing top-down parasympathetic control
  • Vagal dysfunction is a core feature of treatment-resistant depression and anxiety
  1. Kynurenine Pathway Dysregulation
  • Dialister presence (and succinate production) reduces tryptophan shunting into the neurotoxic kynurenine pathway [4]
  • Depletion of Dialister correlates with elevated plasma kynurenine:tryptophan ratios in depression [4]
  • This shift drives quinolinic acid accumulation in the CNS, contributing to excitotoxicity

Oral Health and Periodontitis

Protective Role in Healthy Periodontium

  • Dialister is enriched in healthy gingival tissue and depleted in active periodontitis
  • Produces weak organic acids (lactate, succinate) that maintain gingival pH and inhibit pathogenic species like porphyromonas gingivalis
  • Competes for iron and glycan niches with periodontal pathogens

Periodontitis-Depression Link

  • Patients with severe periodontitis show Dialister depletion in both oral and gut microbiota
  • The shared depletion pattern suggests a systemic dysbiosis extending from oral to enteric compartments
  • Periodontal intervention (plaque removal, antimicrobial rinses) partially restores Dialister in responders

Metal Dependencies

  • Iron: Dialister possesses iron-dependent fermentation enzymes and citrate lyase. Iron restriction may impair succinate production efficiency.
  • Prefers iron-limited conditions in the colon; iron overload (common in dysbiosis-associated states) favors pathogenic competitors

Key Metabolites and Enzymes

  1. Succinate – primary fermentation end-product via the Wood-Ljungdahl pathway
  2. Lactate – secondary fermentation product
  3. Formate – required cofactor for many species; uptake via formate-acetyltransferase
  4. Formate-acetyltransferase (also called pyruvate formate-lyase) – central to succinate and lactate production
  5. Citrate lyase – involved in succinate metabolism

Ecological Interactions

  • Synergistic relationship with other succinate-producing Veillonellaceae (e.g., veillonella)
  • Often co-enriched with blautia and faecalibacterium prausnitzii in healthy microbiota
  • Depleted in dysbiosis states driven by iron overgrowth or high-carbohydrate Western diets
  • Sensitive to antimicrobial agents; often reduced post-antibiotics

Detection and Quantification

  • 16S rRNA profiling: Genus-level quantification via high-throughput sequencing
  • Species-specific qPCR: D. invisus most commonly targeted for functional studies
  • Metabolomics: Serum and fecal succinate levels as proxy for Dialister activity
  • Typical abundance: 0.5–5% of fecal microbiota in healthy individuals; <0.5% in depression

Clinical Relevance and Restoration

  • Dialister-targeting probiotics under development (initial trials promising but limited)
  • Dietary interventions: High-fiber diets and resistant starch selectively enrich Dialister
  • Omega-3 supplementation: May synergize with Dialister restoration in depression
  • Vagal stimulation: Preliminary evidence that VNS combined with microbiota restoration improves Dialister recovery

Connections

  • depression – one of the strongest protective depleted taxa; depletion a biomarker of depressive disorder
  • – depleted in anxiety disorders; shared mechanistic link via vagal signaling
  • gut brain axis – core component of psychobiotic research; succinate and SCFA pathways
  • – depleted in active periodontal disease; shared dysbiosis with oral pathogens
  • – primary producer; succinate supplementation partially rescues depression phenotype
  • short chain fatty acids – co-produces lactate and succinate; contributes to butyrate-producing ecosystem
  • iron – iron-dependent fermentation; iron overload may impair Dialister persistence
  • inflammation – loss increases neuroinflammation via altered LPS and microglia activation
  • – Dialister protects against tryptophan shunting into neurotoxic pathway
  • veillonella – genus family member; shared metabolic pathway
  • blautia – frequently co-enriched in healthy microbiota
  • dysbiosis – Dialister depletion is a key dysbiosis marker across multiple conditions

References (14)

  1. Lepeng Zhou, Linghong Tang, Chuhui Zhou et al. (2024). Zhou 2024 — Association of Maternal Postpartum Depression Symptoms with Infant Neurodevelopment and Gut Microbiota. Frontiers in Psychiatry. doi:10.3389/fpsyt.2024.1385229
  2. Kaitlin Romano, Ashka N. Shah, Anett Schumacher et al. (2023). Romano 2023 — Gut Microbiome in Children with Mood, Anxiety, and NDDs: Umbrella Review. Gut Microbiome. doi:10.1017/gmb.2023.16
  3. Leanne K. Mitchell, Helen S. Heussler, Christopher J. Burgess et al. (2024). Mitchell 2024 — Gastrointestinal, Behaviour and Anxiety Outcomes in Autistic Children Following Synbiotics vs Gut-Directed Hypnotherapy. Journal of Autism and Developmental Disorders. doi:10.1007/s10803-024-06588-9
  4. Peng A, et al. (2023). Peng 2023 — Gut Microbiome and Brain Metabolic Remodeling in CP with Epilepsy. Frontiers in Neurology. doi:10.3389/fneur.2023.1109469
  5. Yuling Chen, Chang Chen (2023). Chen, Chen 2023 — Gut microbiota, inflammatory proteins and COVID-19: a Mendelian randomisation study. Frontiers in Immunology. doi:10.3389/fimmu.2024.1406291
  6. Yumei Zhou, Chen Chen, Haibo Yu et al. (2020). Zhou 2020 — Fecal Microbiota Changes in Patients With Postpartum Depressive Disorder. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2020.567268
  7. Ishaq HM, Mohammad IS, Guo H et al. (2017). Molecular Estimation of Alteration in Intestinal Microbial Composition in Hashimoto's Thyroiditis Patients. Biomedicine and Pharmacotherapy. doi:10.1016/j.biopha.2017.08.101
  8. Francesco Strati, Duccio Cavalieri, Davide Albanese et al. (2017). Strati 2017 — New Evidences on the Altered Gut Microbiota in Autism Spectrum Disorders. Microbiome. doi:10.1186/s40168-017-0242-1
  9. Su X, Yin X, Liu Y et al. (2020). Alteration in gut microbiota is associated with immune imbalance in Graves' disease. EBioMedicine. doi:10.1016/j.ebiom.2020.102952
  10. Yang M, Zheng X, Wu Y et al. (2022). Preliminary Observation of the Changes in the Intestinal Flora of Patients With Graves' Disease Before and After Methimazole Treatment. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2022.794711
  11. Baris Ata, Sule Yildiz, Engin Turkgeldi et al. (2019). Ata 2019 — The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy Controls. Scientific Reports. doi:10.1038/s41598-019-39700-6
  12. S. A. Roberts, L. Brabin, S. Diallo et al. (2019). Roberts 2019 — Mucosal Lactoferrin Response to Genital Tract Infections Is Associated with Iron and Nutritional Biomarkers. European Journal of Clinical Nutrition. doi:10.1038/s41430-019-0444-7
  13. Feitong Liu, Jie Li, Fan Wu et al. (2019). Liu 2019 — Altered Composition and Function of Intestinal Microbiota in ASD: A Systematic Review. Translational Psychiatry. doi:10.1038/s41398-019-0389-6
  14. Tiffany L Weir, Daniel K Manter, Amy M Sheflin et al. (2013). Stool Microbiome and Metabolome Differences between Colorectal Cancer Patients and Healthy Adults. PLoS ONE. doi:10.1371/journal.pone.0070803

Related Articles